Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intersectin - many facets of a scaffold protein.
Mintoo M, Rajagopalan V, O'Bryan JP. Mintoo M, et al. Among authors: o bryan jp. Biochem Soc Trans. 2024 Feb 28;52(1):1-13. doi: 10.1042/BST20211241. Biochem Soc Trans. 2024. PMID: 38174740 Review.
Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors.
Akkapeddi P, Hattori T, Khan I, Glasser E, Koide A, Ketavarapu G, Whaby M, Zuberi M, Teng KW, Lefler J, Maso L, Bang I, Ostrowski MC, O'Bryan JP, Koide S. Akkapeddi P, et al. Among authors: o bryan jp. Proc Natl Acad Sci U S A. 2023 Jul 11;120(28):e2302485120. doi: 10.1073/pnas.2302485120. Epub 2023 Jul 3. Proc Natl Acad Sci U S A. 2023. PMID: 37399416 Free PMC article.
Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway.
Sofi MH, Tian L, Schutt S, Khan I, Choi HJ, Wu Y, Bastian D, Ticer T, Kassir MF, Atilgan FC, Kim J, Sui X, Zivkovic A, Mehrotra S, O'Bryan JP, Stark H, Martin PJ, Ogretmen B, Yu XZ. Sofi MH, et al. Among authors: o bryan jp. Leukemia. 2022 Jul;36(7):1907-1915. doi: 10.1038/s41375-022-01581-6. Epub 2022 May 5. Leukemia. 2022. PMID: 35513703 Free PMC article.
Preface.
O'Bryan JP, Piazza GA. O'Bryan JP, et al. Adv Cancer Res. 2022;153:xiii-xiv. doi: 10.1016/S0065-230X(22)00012-4. Adv Cancer Res. 2022. PMID: 35101237 No abstract available.
Targeting the "undruggable" RAS with biologics.
Whaby M, Khan I, O'Bryan JP. Whaby M, et al. Among authors: o bryan jp. Adv Cancer Res. 2022;153:237-266. doi: 10.1016/bs.acr.2021.07.006. Epub 2021 Aug 13. Adv Cancer Res. 2022. PMID: 35101232 Free PMC article. Review.
74 results